5-methoxy-3-phenoxybenzothiophene-2-carboxylic acid | 122024-65-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 5-methoxy-3-phenoxybenzothiophene-2-carboxylic acid
• 英文别名: 5-methoxy-3-phenoxy-benzo[b]thiophene-2-carboxylic acid；5-Methoxy-3-phenoxy-1-benzothiophene-2-carboxylic acid
• CAS: 122024-65-1
• 化学式: C₁₆H₁₂O₄S
• 分子量: 300.335
• InChiKey: DZZOXSQSQDPELK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  21
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  84
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  5-methoxy-3-phenoxybenzothiophene-2-carboxylic acid 生成 5-Methoxy-3-phenoxy-N-1H-tetrazol-5-yl-benzo [b]thiophene-2-carboxamide
  参考文献：
  名称：

  CONNOR, DAVID T.;MULLICAN, MICHAEL D.;SORENSON, RODERICK J.;THUESON, DAVI+

  摘要：

  DOI：
• 作为产物：
  描述：

  3-chloro-5-methoxy-benzo[b]thiophene-2-carboxylic acid phenyl ester 在 lithium hydroxide 、 三甲基氯硅烷 、 水 、 双氧水 、 sodium hydride 、 三氟乙酸 、 sodium iodide 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 甲醇 、 二氯甲烷 、 水 、 乙腈 为溶剂， 反应 18.75h， 生成 5-methoxy-3-phenoxybenzothiophene-2-carboxylic acid
  参考文献：
  名称：

  [EN] 3-ARYLOXY AND 3-HETEROARYLOXY SUBSTITUTED BENZO(B) THIOPHENES AS THERAPEUTIC AGENTS WITH PI3K ACTIVITY
  [FR] BENZO[B]THIOPHENES A SUBSTITUTION 3-ARYLOXY ET 3-HETEROARYLOXY EN TANT QU'AGENTS THERAPEUTIQUES A ACTIVITE PI3K

  摘要：

  本发明提供了式(I)的苯并[b]噻吩，其中R1、R2、R3、R4、R5和L具有规范中为其定义的任何值，以及药用可接受的盐，这些盐作为治疗疾病和状况的药剂是有用的，包括炎性疾病、心血管疾病和癌症。另外还提供了包含一个或多个式(I)化合物的药物组合物。

  公开号：

  WO2004108715A1

文献信息

• Inhibition of E-Selectin-, ICAM-1-, and VCAM-1-Mediated Cell Adhesion by Benzo[b]thiophene-, Benzofuran-, Indole-, and Naphthalene-2-carboxamides: Identification of PD 144795 as an Antiinflammatory Agent
  作者：Diane H. Boschelli、James B. Kramer、Sonya S. Khatana、Roderick J. Sorenson、David T. Connor、Mark A. Ferin、Clifford D. Wright、Mark E. Lesch、Kathleen Imre

  DOI：10.1021/jm00022a026

  日期：1995.10

  reported that 3-alkoxybenzo[b]thiophene-2-carboxamides exemplified by 1, 5-methoxy-3-(1-methylethoxy)benzo[b]thiophene-2-carboxamide, decreased the adherence of neutrophils to activated endothelial cells by inhibiting the upregulation of the adhesion molecules E-selectin and ICAM-1 on the surface of the endothelium. This finding is extended here to a series of 3-thiobenzo[b]thiophene-2-carboxamides and also

  以前有报道说，以1，5-甲氧基-3-（1-甲基乙氧基）苯并[b]噻吩-2-羧酰胺为例的3-烷氧基苯并[b]噻吩-2-甲酰胺降低了中性粒细胞对活化内皮细胞的粘附通过抑制内皮细胞表面粘附分子E-选择素和ICAM-1的上调。该发现在这里扩展到一系列的3-硫代苯并[b]噻吩-2-羧酰胺以及1的杂环类似物，包括苯并呋喃，吲哚和萘。抑制E-选择蛋白和ICAM-1表达的化合物对VCAM-1的表达具有相同的作用。PD 144795，亚砜类似物1，即5-甲氧基-3-（1-甲基乙氧基）苯并[b]噻吩-2-羧酰胺1-氧化物（44）在几种炎症模型中具有口服活性。
• 3-alkyloxy-, aryloxy-, or arylalkyloxy-benzo
  申请人：Warner-Lambert Company

  公开号：US05356926A1

  公开（公告）日：1994-10-18

  3-Alkyloxy-, aryloxy-, or arylalkyloxybenzo[b]-thiophene-2-carboxamides are described as agents which block leukocyte adherence to vascular endothelium and, as such, are effective therapeutic agents for treating inflammatory diseases. Certain of these compounds are novel and methods of preparation are also described.

  本文描述了3-烷氧基、芳氧基或芳基烷氧基苯并[b]-噻吩-2-羧酰胺作为阻止白细胞粘附于血管内皮的药物，因此是治疗炎症性疾病的有效治疗剂。其中某些化合物是新颖的，并且还描述了其制备方法。
• 3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
  申请人：——

  公开号：US20040259926A1

  公开（公告）日：2004-12-23

  The present invention provides benzo[b]thiophenes of Formula I: 1 wherein R 1 , R 2 , R 3 , R 4 , R 5 , and L have any of the values defined therefor in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cardiovascular diseases, and cancers. Also provided are pharmaceutical compositions comprising one or more compounds of Formula I.

  本发明提供了式I的苯并[b]噻吩化合物：1其中R1、R2、R3、R4、R5和L在规范中定义的任何值，以及其药学上可接受的盐，可用作治疗疾病和病症的药物，包括炎症性疾病、心血管疾病和癌症。还提供了包含一个或多个式I化合物的药物组合物。
• Novel benzothiophenes having antiallergic activity and both novel and other selected benzothiophenes having activity for treating acute respiratory distress syndrome
  申请人：WARNER-LAMBERT COMPANY

  公开号：EP0299457A2

  公开（公告）日：1989-01-18

  Novel benzothiophenes having antiallergic activity and both novel and other selected benzo­thiophenes having activity for treating acute respiratory distress syndrome. The benzothiophenes of the present invention are particularly 2-tetrazolyl­carboxamides of the benzothiophenes.

  具有抗过敏活性的新型苯并噻吩，以及具有治疗急性呼吸窘迫综合征活性的新型苯并噻吩和其他精选苯并噻吩。本发明的苯并噻吩尤其是苯并噻吩的 2-四唑甲酰胺。
• Novel benzothiophene-, benzofuran-, and naphthalenecarboxamidotetrazoles as potential antiallergy agents
  作者：David T. Connor、Wiaczeslaw A. Cetenko、Michael D. Mullican、Roderick J. Sorenson、Paul C. Unangst、Robert J. Weikert、Richard L. Adolphson、John A. Kennedy、David O. Thueson

  DOI：10.1021/jm00083a023

  日期：1992.3

  The synthesis and antiallergic activity of a series of novel benzothiophene-, benzofuran-, and naphthalenecarbox-amidotetrazoles are described. A number of the compounds inhibit the release of histamine from anti-IgE stimulated basophils obtained from allergic donors. Optimal inhibition is exhibited in benzothiophenes with a 3-alkoxy substituent in combination with a 5-methoxy, 6-methoxy, or a 5,6-dimethoxy group. Compounds 13c (CI-959) also inhibited respiratory burst of human neutrophils and the release of mediators from anti-IgE-stimulated human chopped lung.